P073: Increased risk of colorectal cancer following treatment for Hodgkin lymphoma

• Yvonne M.G. Geurts,
• Rebecca Shakir,
• Georgios Ntentas,
• Sander Roberti,
• Marianne Aznar,
• Katinka John,
• Johanna Ramroth,
• Cécile P.M. Janus,
• Augustinus Krol,
• Judith Roesink,
• Richard W.M. Van Der Maazen,
• Josée. M. Zijlstra,
• Sarah Darby,
• Berthe M. P. Aleman,
• Flora E. Van Leeuwen,
• David Cutter,
• Michael Schaapveld

Affiliations

Yvonne M.G. Geurts

1 Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Rebecca Shakir

2 Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom

Georgios Ntentas

2 Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom

Sander Roberti

1 Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Marianne Aznar

5 Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK

Katinka John

1 Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Johanna Ramroth

2 Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom

Cécile P.M. Janus

6 Department of Radiotherapy, Erasmus Medical Center, Rotterdam, The Netherlands

Augustinus Krol

7 Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands

Judith Roesink

8 Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands

Richard W.M. Van Der Maazen

9 Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands

Josée. M. Zijlstra

10 Department of Hematology, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands

Sarah Darby

11 Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Berthe M. P. Aleman

11 Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Flora E. Van Leeuwen

1 Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands

David Cutter

2 Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom

Michael Schaapveld

1 Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands